Skip to main content
Livermore
Livermore
ZHEN

Werlinich Asset Management, LLC

SEC CIK
0002000493
Latest filing
Jul 9, 2026

DGX holding history

Quest Diagnostics Inc in every 13F filed by Werlinich Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DGX overviewAll 13F holders of DGXFull Q2 2026 holdings

Shares (Q2 2026)
3,080
Value
$652.8K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of DGX by Werlinich Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,080$652.8K0.2%00.0%UnchangedHolders
Q1 20263,080$603.6K0.3%+50+1.7%AddedHolders
Q4 20253,030$531.7K0.3%+120+4.1%AddedHolders
Q3 20252,910$554.6K0.3%00.0%UnchangedHolders
Q2 20252,910$522.7K0.3%−500−14.7%ReducedHolders
Q1 20253,410$577.0K0.4%00.0%UnchangedHolders
Q4 20243,410$514.8K0.3%−345−9.2%ReducedHolders
Q3 20243,755$583.0K0.3%00.0%UnchangedHolders
Q2 20243,755$515.7K0.3%−150−3.8%ReducedHolders
Q1 20243,905$511.8K0.3%−2,910−42.7%ReducedHolders
Q4 20236,815$937.6K0.7%−339−4.7%ReducedHolders
Q3 20237,154$871.8K0.7%+164+2.3%AddedHolders
Q2 20236,990$982.5K0.8%00.0%UnchangedHolders
Q1 20236,990$988.9K0.9%+10+0.1%AddedHolders
Q4 20226,980$1.09M1.0%−85−1.2%ReducedHolders
Q3 20227,065$866.8K0.9%−100−1.4%ReducedHolders
Q2 20227,165$952.8K0.9%−525−6.8%ReducedHolders
Q1 20227,690$1.05M0.8%−245−3.1%ReducedHolders
Q4 20217,935$1.37M1.0%00.0%UnchangedHolders
Q3 20217,935$1.15M0.9%−110−1.4%ReducedHolders
Q2 20218,045$1.06M0.9%00.0%UnchangedHolders
Q1 20218,045$1.03M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.